ADVERTISEMENT
COVID-19, SARS-CoV-2, coronavirus, pandemic, transmission, superspread, genome, virus, tracking, Biogen, Massachusetts
Thousands of Coronavirus Infections Stemmed from a Biotech Event
Officials had initially linked 97 cases to a single conference held by Biogen in February in Boston, but a new study tracking viral genomes suggests the number may be as high as 20,000.
Thousands of Coronavirus Infections Stemmed from a Biotech Event
Thousands of Coronavirus Infections Stemmed from a Biotech Event

Officials had initially linked 97 cases to a single conference held by Biogen in February in Boston, but a new study tracking viral genomes suggests the number may be as high as 20,000.

Officials had initially linked 97 cases to a single conference held by Biogen in February in Boston, but a new study tracking viral genomes suggests the number may be as high as 20,000.

industry, genetics & genomics

Blue Rush: One Company Leads the Race to Own Marine Genetic Sequences
Ruth Williams | Jun 6, 2018 | 3 min read
Almost half of all patents relating to the genes of marine organisms belong to one large international corporation, BASF, a new study reveals.  
Do Patents Promote or Stall Innovation?
Catherine Offord | Jun 1, 2016 | 10 min read
A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.
Former Affymetrix Employees Fail to Stop Thermo Fisher Takeover
Bob Grant | Mar 22, 2016 | 2 min read
Their $1.5 billion bid, which topped Thermo Fisher Scientific’s $1.3 billion offer for the genetic analysis company, was rejected.
23andMe Enters Drug Development
Kerry Grens | Mar 12, 2015 | 2 min read
The personal genomics firm announces plans to make medicines.
23andMe Partners with Pfizer
Jef Akst | Jan 13, 2015 | 1 min read
The personal genomics company strikes yet another deal to glean biomedically relevant information from its user data.
Feds Scrutinize Genomics Merger
Bob Grant | Dec 6, 2012 | 2 min read
A Chinese biotech company is angling to buy California-based Complete Genomics, but federal regulators are expressing security concerns and may scuttle the deal.
BGI Saves Genomics Technology
Jef Akst | Sep 26, 2012 | 2 min read
A large Chinese sequencing center’s purchase of Complete Genomics, a California-based DNA services company, ensures the valued technology will remain on the market.
Best Places to Work Academia, 2012
The Scientist | Aug 1, 2012 | 9 min read
On the 10th anniversary of The Scientist’s survey of life science academics, institutions are contending with tighter budgets and larger administrative staffs, while working to sustain and inspire their researchers.
Honey bee microbiome probed
Bob Grant | Jun 9, 2011 | 1 min read
Researchers reveal several new viruses lurking in healthy hives.
Drought-tolerant corn trials underwater
Bob Grant | May 26, 2011 | 1 min read
Agribusiness giant Monsanto is finding out that it's difficult to conduct field trials of drought-resistant corn when it won't stop raining. The company hopes to launch a new line of corn seed that's been genetically engineered to thrive in drough conditions by 2013.
Billion dollar babies of the human genome
Jef Akst | May 14, 2011 | 2 min read
The Human Genome Project has generated nearly $800 billion in economic output and hundreds of thousands of jobs in genomics and related industries.
ADVERTISEMENT